Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Adjusting Batch Sizes According to Production Needs – V 2.0

Posted on By

SOP for Adjusting Batch Sizes According to Production Needs – V 2.0

Procedure for Adjusting Batch Sizes According to Production Needs

Department Manufacturing/Production/Quality Assurance (QA)/Quality Control (QC)/Planning
SOP No. SOP/Ointment/197
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for adjusting batch sizes in ointment production to align with market demand, production efficiency, and resource availability while ensuring compliance with GMP regulations.

2. Scope

This SOP applies to manufacturing, production planning, and quality assurance personnel involved in determining and adjusting batch sizes in accordance with production needs.

3. Responsibilities

  • Production Manager: Ensures batch size adjustments comply with GMP and regulatory requirements.
  • Planning Department: Analyzes market demand, forecasts production needs, and proposes batch adjustments.
  • QA Officer: Verifies that changes in batch size do not affect product quality or stability.
  • QC Analyst: Conducts required tests to ensure consistency across different batch sizes.
  • Manufacturing Supervisor: Implements the approved batch size adjustments and documents changes.
See also  Ointments: SOP for Cross-Contamination Risk Assessment - V 2.0

4. Accountability

The Head of Production is accountable for ensuring that batch size adjustments follow GMP guidelines and maintain product quality standards.

5. Procedure

5.1 Reviewing Production Needs

  • Assess demand fluctuations using sales forecasts and market analysis.
  • Evaluate current production capacity and resource availability.
  • Document production requirements in the **Batch Size Adjustment
Log (Annexure-1).**

5.2 Determining Batch Adjustment Parameters

  • Identify allowable batch size variations based on equipment capacity.
  • Ensure batch adjustments do not affect critical quality attributes (CQAs).
  • Record planned adjustments in the **Batch Adjustment Plan (Annexure-2).**

5.3 Implementing Batch Adjustments

  • Obtain QA and regulatory approval before modifying batch sizes.
  • Communicate batch size changes to all relevant departments.
  • Maintain documentation in the **Batch Adjustment Implementation Log (Annexure-3).**

5.4 Post-Adjustment Quality Control

  • Conduct in-process and finished product testing for adjusted batches.
  • Compare quality data with historical batch records.
  • Document test results in the **Quality Verification Report (Annexure-4).**

6. Abbreviations

  • GMP – Good Manufacturing Practices
  • QA – Quality Assurance
  • QC – Quality Control
  • CQA – Critical Quality Attributes
  • SOP – Standard Operating Procedure

7. Documents

  • Batch Size Adjustment Log (Annexure-1)
  • Batch Adjustment Plan (Annexure-2)
  • Batch Adjustment Implementation Log (Annexure-3)
  • Quality Verification Report (Annexure-4)

8. References

  • FDA Guidance on Process Validation
  • ICH Q8 – Pharmaceutical Development Guidelines
  • WHO Guidelines on Production Planning

9. SOP Version

Version 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Batch Size Adjustment Log

Date Batch No. Current Batch Size Adjusted Batch Size Reason for Adjustment QA Approval
04/02/2025 OINT-7001 500 kg 750 kg Increased demand Approved

Annexure-2: Batch Adjustment Plan

Date Batch No. Adjustment Plan Equipment Capacity Verified QA Approval
04/02/2025 OINT-7001 Increase batch by 50% Yes Approved

Annexure-3: Batch Adjustment Implementation Log

Date Batch No. Adjustment Implemented Deviation Noted QA Approval
05/02/2025 OINT-7001 Yes No Approved

Annexure-4: Quality Verification Report

Date Batch No. Quality Test Performed Result QA Approval
06/02/2025 OINT-7001 Viscosity Check Pass Approved

12. Revision History

Revision Date Revision No. Details Reason Approved By
06/02/2025 2.0 Updated batch adjustment process Process Optimization QA Head
01/01/2024 1.0 Initial SOP New SOP Implementation QA Head
See also  Ointments: SOP for Preparing Stability Study Reports - V 2.0
Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

Post navigation

Previous Post: Creams: SOP for Avoiding Air Entrainment in Cream Manufacturing – V 2.0
Next Post: Capsule: SOP for Capsule Weight Variation Testing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version